FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

375958006: Terazosin hydrochloride 5mg tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1201266018 Terazosin hydrochloride 5mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1214265012 Terazosin hydrochloride 5mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1201266018 Terazosin hydrochloride 5mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1201266018 Terazosin hydrochloride 5mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1214265012 Terazosin hydrochloride 5mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1214265012 Terazosin hydrochloride 5mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Terazosin hydrochloride 5mg tablet Is a Product containing alpha-1 adrenergic receptor antagonist (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Terazosin hydrochloride 5mg tablet Is a Terazosin hydrochloride false Inferred relationship Existential restriction modifier (core metadata concept)
    Terazosin hydrochloride 5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Terazosin false Inferred relationship Existential restriction modifier (core metadata concept)
    Terazosin hydrochloride 5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Terazosin hydrochloride (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Terazosin hydrochloride 5mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start